• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前磁共振成像放射组学预测胶质母细胞瘤早期复发

Preoperative Magnetic Resonance Imaging Radiomics for Predicting Early Recurrence of Glioblastoma.

作者信息

Wang Jing, Yi Xiaoping, Fu Yan, Pang Peipei, Deng Huihuang, Tang Haiyun, Han Zaide, Li Haiping, Nie Jilin, Gong Guanghui, Hu Zhongliang, Tan Zeming, Chen Bihong T

机构信息

Department of Radiology, Xiangya Hospital, Central South University, Changsha, China.

National Clinical Research Center for Geriatric Disorders, Changsha, China.

出版信息

Front Oncol. 2021 Oct 27;11:769188. doi: 10.3389/fonc.2021.769188. eCollection 2021.

DOI:10.3389/fonc.2021.769188
PMID:34778086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8579096/
Abstract

PURPOSE

Early recurrence of glioblastoma after standard treatment makes patient care challenging. This study aimed to assess preoperative magnetic resonance imaging (MRI) radiomics for predicting early recurrence of glioblastoma.

PATIENTS AND METHODS

A total of 122 patients (training cohort: n = 86; validation cohort: n = 36) with pathologically confirmed glioblastoma were included in this retrospective study. Preoperative brain MRI images were analyzed for both radiomics and the Visually Accessible Rembrandt Image (VASARI) features of glioblastoma. Models incorporating MRI radiomics, the VASARI parameters, and clinical variables were developed and presented in a nomogram. Performance was assessed based on calibration, discrimination, and clinical usefulness.

RESULTS

The nomogram consisting of the radiomic signatures, the VASARI parameters, and blood urea nitrogen (BUN) values showed good discrimination between the patients with early recurrence and those with later recurrence, with an area under the curve of 0.85 (95% CI, 0.77-0.94) in the training cohort and 0.84 [95% CI, 0.71-0.97] in the validation cohort. Decision curve analysis demonstrated favorable clinical application of the nomogram.

CONCLUSION

This study showed the potential usefulness of preoperative brain MRI radiomics in predicting the early recurrence of glioblastoma, which should be helpful in personalized management of glioblastoma.

摘要

目的

胶质母细胞瘤在标准治疗后早期复发给患者护理带来挑战。本研究旨在评估术前磁共振成像(MRI)的放射组学特征以预测胶质母细胞瘤的早期复发。

患者与方法

本回顾性研究纳入了122例经病理证实的胶质母细胞瘤患者(训练队列:n = 86;验证队列:n = 36)。对术前脑MRI图像进行放射组学分析以及胶质母细胞瘤的视觉可及性Rembrandt图像(VASARI)特征分析。构建了包含MRI放射组学特征、VASARI参数和临床变量的模型,并以列线图形式呈现。基于校准、鉴别能力和临床实用性对模型性能进行评估。

结果

由放射组学特征、VASARI参数和血尿素氮(BUN)值组成的列线图在早期复发患者和晚期复发患者之间显示出良好的鉴别能力,训练队列中的曲线下面积为0.85(95%CI,0.77 - 0.94),验证队列中的曲线下面积为0.84[95%CI,0.71 - 0.97]。决策曲线分析表明该列线图具有良好的临床应用价值。

结论

本研究表明术前脑MRI放射组学在预测胶质母细胞瘤早期复发方面具有潜在的应用价值,这有助于胶质母细胞瘤的个体化管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7f/8579096/03c91e9c5510/fonc-11-769188-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7f/8579096/1f0ba21b5912/fonc-11-769188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7f/8579096/37386808e6ba/fonc-11-769188-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7f/8579096/c24fbfe70da1/fonc-11-769188-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7f/8579096/6624202031b0/fonc-11-769188-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7f/8579096/03c91e9c5510/fonc-11-769188-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7f/8579096/1f0ba21b5912/fonc-11-769188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7f/8579096/37386808e6ba/fonc-11-769188-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7f/8579096/c24fbfe70da1/fonc-11-769188-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7f/8579096/6624202031b0/fonc-11-769188-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af7f/8579096/03c91e9c5510/fonc-11-769188-g005.jpg

相似文献

1
Preoperative Magnetic Resonance Imaging Radiomics for Predicting Early Recurrence of Glioblastoma.术前磁共振成像放射组学预测胶质母细胞瘤早期复发
Front Oncol. 2021 Oct 27;11:769188. doi: 10.3389/fonc.2021.769188. eCollection 2021.
2
Nomogram incorporating preoperative MRI-VASARI features for differentiating intracranial extraventricular ependymoma from glioblastoma.纳入术前MRI-VASARI特征的列线图,用于鉴别颅内脑室外室管膜瘤与胶质母细胞瘤。
Quant Imaging Med Surg. 2024 Mar 15;14(3):2255-2266. doi: 10.21037/qims-23-1148. Epub 2024 Mar 7.
3
The combination of radiomics features and VASARI standard to predict glioma grade.联合影像组学特征与VASARI标准预测胶质瘤分级。
Front Oncol. 2023 Mar 22;13:1083216. doi: 10.3389/fonc.2023.1083216. eCollection 2023.
4
Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.基于 MRI 的放射组学列线图预测骨肉瘤早期复发的建立与外部验证:一项回顾性多中心研究。
Eur J Radiol. 2020 Aug;129:109066. doi: 10.1016/j.ejrad.2020.109066. Epub 2020 May 17.
5
A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.基于多参数 MRI 的放射组学列线图可根据生存情况对胶质母细胞瘤患者进行分层。
Eur Radiol. 2019 Oct;29(10):5528-5538. doi: 10.1007/s00330-019-06069-z. Epub 2019 Mar 7.
6
Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma.基于机器学习的放射组学、临床和语义特征分析预测胶质母细胞瘤患者的总生存期和 MGMT 启动子甲基化状态。
Magn Reson Imaging. 2020 Dec;74:161-170. doi: 10.1016/j.mri.2020.09.017. Epub 2020 Sep 25.
7
Multi-parameter MRI based radiomics nomogram for predicting telomerase reverse transcriptase promoter mutation and prognosis in glioblastoma.基于多参数磁共振成像的影像组学列线图预测胶质母细胞瘤中端粒酶逆转录酶启动子突变及预后
Front Neurol. 2023 Sep 26;14:1266658. doi: 10.3389/fneur.2023.1266658. eCollection 2023.
8
Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study.基于多参数 MRI 的影像组学列线图构建预测胶质瘤患者分级的模型:一项队列研究。
J Magn Reson Imaging. 2019 Mar;49(3):825-833. doi: 10.1002/jmri.26265. Epub 2018 Sep 8.
9
Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.基于 MRI 的影像组学预后分类器在原发性多形性胶质母细胞瘤患者中的建立与验证。
Acad Radiol. 2019 Oct;26(10):1292-1300. doi: 10.1016/j.acra.2018.12.016. Epub 2019 Jan 17.
10
A radiomics-clinical nomogram for preoperative prediction of IDH1 mutation in primary glioblastoma multiforme.原发性胶质母细胞瘤 IDH1 突变的术前预测放射组学-临床列线图
Clin Radiol. 2020 Dec;75(12):963.e7-963.e15. doi: 10.1016/j.crad.2020.07.036. Epub 2020 Sep 10.

引用本文的文献

1
Biopsy location and tumor-associated macrophages in predicting malignant glioma recurrence using an in-silico model.使用计算机模拟模型,活检部位和肿瘤相关巨噬细胞在预测恶性胶质瘤复发中的作用
NPJ Syst Biol Appl. 2025 Jan 8;11(1):3. doi: 10.1038/s41540-024-00478-7.
2
VASARI-auto: Equitable, efficient, and economical featurisation of glioma MRI.VASARI-auto:脑胶质瘤 MRI 的公平、高效和经济的特征化。
Neuroimage Clin. 2024;44:103668. doi: 10.1016/j.nicl.2024.103668. Epub 2024 Sep 6.
3
Prediction of early recurrence of adult-type diffuse gliomas following radiotherapy using multi-modal magnetic resonance images.

本文引用的文献

1
Pre-treatment CT-based radiomics nomogram for predicting microsatellite instability status in colorectal cancer.基于治疗前 CT 的放射组学列线图预测结直肠癌微卫星不稳定性状态。
Eur Radiol. 2022 Jan;32(1):714-724. doi: 10.1007/s00330-021-08167-3. Epub 2021 Jul 13.
2
Uncovering a Distinct Gene Signature in Endothelial Cells Associated With Contrast Enhancement in Glioblastoma.发现与胶质母细胞瘤对比增强相关的内皮细胞中独特的基因特征。
Front Oncol. 2021 Jun 17;11:683367. doi: 10.3389/fonc.2021.683367. eCollection 2021.
3
Decongestion discriminates risk for one-year mortality in patients with improving renal function in acute heart failure.
多模态磁共振成像预测成人弥漫性胶质瘤放疗后早期复发。
Med Phys. 2024 Nov;51(11):8638-8648. doi: 10.1002/mp.17382. Epub 2024 Sep 2.
4
Ten Years of VASARI Glioma Features: Systematic Review and Meta-Analysis of Their Impact and Performance.VASARI 胶质瘤特征十年:系统评价和荟萃分析及其影响和性能。
AJNR Am J Neuroradiol. 2024 Aug 9;45(8):1053-1062. doi: 10.3174/ajnr.A8274.
5
Multi-parameter MRI based radiomics nomogram for predicting telomerase reverse transcriptase promoter mutation and prognosis in glioblastoma.基于多参数磁共振成像的影像组学列线图预测胶质母细胞瘤中端粒酶逆转录酶启动子突变及预后
Front Neurol. 2023 Sep 26;14:1266658. doi: 10.3389/fneur.2023.1266658. eCollection 2023.
6
Concept of a fully-implantable system to monitor tumor recurrence.用于监测肿瘤复发的全植入式系统的概念。
Sci Rep. 2023 Sep 29;13(1):16362. doi: 10.1038/s41598-023-43226-3.
7
One Step Forward-The Current Role of Artificial Intelligence in Glioblastoma Imaging.向前迈进一步——人工智能在胶质母细胞瘤成像中的当前作用
Life (Basel). 2023 Jul 14;13(7):1561. doi: 10.3390/life13071561.
8
Vasari Scoring System in Discerning between Different Degrees of Glioma and IDH Status Prediction: A Possible Machine Learning Application?瓦萨里评分系统在鉴别不同程度胶质瘤及预测异柠檬酸脱氢酶(IDH)状态中的应用:一种可能的机器学习应用?
J Imaging. 2023 Mar 24;9(4):75. doi: 10.3390/jimaging9040075.
9
The combination of radiomics features and VASARI standard to predict glioma grade.联合影像组学特征与VASARI标准预测胶质瘤分级。
Front Oncol. 2023 Mar 22;13:1083216. doi: 10.3389/fonc.2023.1083216. eCollection 2023.
10
PLVAP is associated with glioma-associated malignant processes and immunosuppressive cell infiltration as a promising marker for prognosis.PLVAP与胶质瘤相关的恶性过程及免疫抑制细胞浸润相关,是一种有前景的预后标志物。
Heliyon. 2022 Aug 19;8(8):e10298. doi: 10.1016/j.heliyon.2022.e10298. eCollection 2022 Aug.
在急性心力衰竭患者肾功能改善的情况下,利尿可区分一年死亡率的风险。
Eur J Heart Fail. 2021 Jul;23(7):1122-1130. doi: 10.1002/ejhf.2179. Epub 2021 Apr 15.
4
Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.近红外荧光纳米平台用于胶质母细胞瘤的靶向术中切除和化学治疗。
ACS Nano. 2020 Jul 28;14(7):8392-8408. doi: 10.1021/acsnano.0c02509. Epub 2020 Jun 23.
5
Radiomics prognostication model in glioblastoma using diffusion- and perfusion-weighted MRI.基于扩散加权和灌注加权 MRI 的脑胶质母细胞瘤放射组学预后模型。
Sci Rep. 2020 Mar 6;10(1):4250. doi: 10.1038/s41598-020-61178-w.
6
Vascular architecture mapping for early detection of glioblastoma recurrence.血管结构图谱用于胶质母细胞瘤复发的早期检测。
Neurosurg Focus. 2019 Dec 1;47(6):E14. doi: 10.3171/2019.9.FOCUS19613.
7
First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma.首个人体药理学试验:联合使用药物 ASC 与放疗、替莫唑胺治疗新诊断的胶质母细胞瘤。
Clin Cancer Res. 2019 Nov 15;25(22):6590-6597. doi: 10.1158/1078-0432.CCR-19-0594. Epub 2019 Aug 19.
8
A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort.一项纳入肿瘤药效动力学和药代动力学指导扩展队列的复发性胶质母细胞瘤患者中使用瑞博西利的 0 期临床试验。
Clin Cancer Res. 2019 Oct 1;25(19):5777-5786. doi: 10.1158/1078-0432.CCR-19-0133. Epub 2019 Jul 8.
9
Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 Study.复发性脑胶质瘤动态对比增强 MRI 的读者间可变性:多中心 ACRIN 6677/RTOG 0625 研究。
Radiology. 2019 Feb;290(2):467-476. doi: 10.1148/radiol.2019181296. Epub 2018 Nov 27.
10
Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma.多参数 PET 和 MRI 预测胶质母细胞瘤患者肿瘤复发的可行性。
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):603-613. doi: 10.1007/s00259-018-4180-3. Epub 2018 Oct 2.